Our Pricing

Cheapest Weight Loss Injections - UK Lowest Prices

Published on: June 03, 2026

Searching for the cheapest weight loss injections UK pharmacies offer? At Cured Pharmacy, we provide transparent upfront pricing on all prescription weight loss treatments, with Saxenda starting from £135.00 Wegovy from £135.00 and Mounjaro from £135.00. Every treatment includes a free clinical assessment by our UK-registered prescribers, with no hidden consultation fees.

How Weight Loss Injections Work: The Science Behind GLP-1 Treatments

Weight loss injections available in the UK belong to a class of medications called GLP-1 receptor agonists, which mimic natural hormones that regulate appetite and blood sugar. These medications work by slowing gastric emptying, reducing hunger signals in the brain, and improving insulin sensitivity [1]. The result is a significant reduction in calorie intake without the intense hunger that typically derails weight loss efforts.

Mounjaro represents the latest advancement in this field as the first dual GIP/GLP-1 receptor agonist licensed by the MHRA. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 pathways simultaneously, tirzepatide produces greater weight reduction than single-pathway treatments [2]. In the SURMOUNT-1 trial, participants achieved an average weight loss of 20.9% over 72 weeks on the highest dose, compared to 2.4% with placebo [2].

Wegovy and Saxenda both contain semaglutide and liraglutide respectively, which work exclusively on GLP-1 receptors. While highly effective, these single-pathway treatments typically produce slightly less weight reduction than dual-action alternatives. The STEP-1 trial demonstrated that semaglutide 2.4mg resulted in an average 14.9% weight loss over 68 weeks [3]. All three medications require subcutaneous injection and are prescription-only in the UK, necessitating clinical assessment by a registered prescriber.

Comparing Weight Loss Injection Prices: What You're Actually Paying For

Price transparency remains frustratingly rare in the UK online pharmacy market, with many providers hiding costs behind mandatory consultation fees. At Cured Pharmacy, we display upfront pricing before you begin your clinical assessment, ensuring you can make informed decisions about your treatment journey. Our prices reflect the genuine cost of UK-licensed medication, clinical oversight by GPhC-registered prescribers, and discreet home delivery.

The price variation between different weight loss injections reflects several factors: manufacturing complexity, dosing frequency, and clinical efficacy data. Saxenda requires daily injections, which explains the lower per-pen cost but higher long-term commitment. Wegovy and Mounjaro are both once-weekly injections, offering greater convenience. Mounjaro's higher price point reflects its dual-action mechanism and superior weight loss outcomes in head-to-head trials [4].

When comparing costs across UK pharmacies, be wary of artificially low advertised prices that exclude mandatory consultation fees, delivery charges, or follow-up appointments. At Cured Pharmacy, our stated prices include your free clinical consultation with a UK prescriber, and we never add hidden fees at checkout. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), personally oversees our pricing structure to ensure we maintain the UK's most competitive rates whilst never compromising on clinical safety.

Understanding Dosing and Cost Progression

All GLP-1 weight loss injections follow a dose-escalation protocol, starting at a lower dose and gradually increasing over several weeks to minimise side effects. Your initial prescription will typically cover the starter dose, with subsequent prescriptions adjusted based on your tolerance and clinical response. This titration schedule means your monthly cost may increase as you progress through higher dose strengths, though many patients find their appetite reduction allows them to offset medication costs through reduced food spending.

Mounjaro vs Wegovy vs Saxenda: Clinical Outcomes and Patient Experience

Choosing between weight loss injections requires understanding both clinical trial data and real-world patient experience. Mounjaro (tirzepatide) consistently demonstrates the highest weight reduction in clinical trials, with the 15mg dose producing an average 22.5% body weight loss in the SURPASS-3 trial [5]. Wegovy (semaglutide 2.4mg) achieves approximately 14.9% average weight loss, whilst Saxenda (liraglutide 3mg) produces around 8% weight reduction over 56 weeks [3][6].

Beyond the numbers, patient preference often hinges on injection frequency and side effect profiles. Saxenda's daily injection schedule provides steady hormone levels but requires greater commitment to routine. Wegovy and Mounjaro's once-weekly dosing offers convenience, though some patients report more pronounced gastrointestinal side effects in the 48 hours following injection. Nausea, diarrhoea, and constipation occur across all three medications, typically diminishing after the first 4-8 weeks as your body adapts [1].

Your UK prescriber will assess multiple factors when recommending a specific treatment: your BMI, weight loss goals, previous medication trials, concurrent health conditions, and budget constraints. Patients with type 2 diabetes may particularly benefit from Mounjaro's superior glycaemic control, whilst those seeking the most affordable entry point often begin with Saxenda. There's no universally 'best' option—the right choice depends on your individual clinical picture and lifestyle preferences.

What to Expect in Your First 12 Weeks

The initial three months on any GLP-1 weight loss injection involve dose titration and adaptation. Most patients notice reduced appetite within the first week, though significant weight loss typically begins after reaching therapeutic doses around week 4-8. Expect to lose 5-10% of your body weight in the first three months if you're responding well to treatment, with continued steady loss thereafter. Your prescriber will schedule follow-up assessments to monitor progress, adjust dosing, and address any side effects that emerge.

Cheapest Weight Loss Injections UK: How Cured Pharmacy Maintains Low Prices

Our ability to offer the UK's lowest prices on prescription weight loss injections stems from our operational model. As a fully digital pharmacy (GPhC registration 9012511), we eliminate the overhead costs of physical premises whilst maintaining the same rigorous clinical standards as traditional pharmacies. Our streamlined online consultation process takes under three minutes, reducing administrative burden without compromising prescriber thoroughness.

We work directly with UK-licensed wholesalers and maintain optimal stock levels to secure volume pricing on high-demand medications. These savings pass directly to patients—we don't inflate prices to fund expensive marketing campaigns or celebrity endorsements. Every medication dispensed from Cured Pharmacy is sourced through legitimate UK supply chains and carries full MHRA licensing, ensuring you receive genuine products at the lowest possible cost.

Our price guarantee is straightforward: if you find a lower price from another UK-registered pharmacy for the same medication and dose, we'll match it. This commitment reflects our confidence in our pricing structure and our mission to make evidence-based weight loss treatments accessible to more UK patients. Superintendent pharmacist Tarun Kumar reviews our pricing monthly against market rates to ensure we maintain our position as the UK's most affordable option for prescription weight loss injections.

The Clinical Assessment Process: What UK Prescribers Evaluate

All prescription weight loss injections require clinical assessment by a UK-registered prescriber before dispensing—this is a legal requirement, not an optional extra. Our online consultation takes approximately three minutes and covers essential medical history: current BMI, previous weight loss attempts, existing health conditions, current medications, and any contraindications to GLP-1 therapy. This assessment protects your safety and ensures the prescribed treatment suits your individual circumstances.

UK prescribing guidelines for weight loss injections specify eligibility criteria based on NICE recommendations. Generally, you'll need a BMI of 30 or above, or 27 with weight-related health conditions such as type 2 diabetes, hypertension, or sleep apnoea [7]. Our prescribers also consider factors like previous bariatric surgery, history of pancreatitis, family history of medullary thyroid carcinoma, and concurrent use of other weight loss medications. If a prescriber determines that weight loss injections aren't clinically appropriate for you, they'll explain why and may suggest alternative treatments.

Following your initial prescription, ongoing monitoring ensures treatment remains safe and effective. Most patients require follow-up consultations every 8-12 weeks to assess weight loss progress, manage side effects, and adjust dosing. At Cured Pharmacy, these follow-up assessments are included at no additional cost—we never charge repeated consultation fees for continuing prescriptions. Your prescriber may request blood tests through your NHS GP to monitor kidney function and blood glucose, particularly if you have pre-existing health conditions.

Contraindications and Safety Considerations

Weight loss injections aren't suitable for everyone. Absolute contraindications include pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, and multiple endocrine neoplasia syndrome type 2. Relative contraindications requiring careful prescriber evaluation include history of pancreatitis, severe gastrointestinal disease, diabetic retinopathy, and renal impairment. Always disclose your complete medical history during consultation—withholding information compromises your safety and may result in serious adverse effects.

Maximising Results: Lifestyle Factors That Enhance Weight Loss Injection Efficacy

Weight loss injections are most effective when combined with dietary modifications and increased physical activity. Clinical trials demonstrating impressive weight loss percentages all included lifestyle intervention components alongside medication [2][3]. The injections reduce hunger and create a caloric deficit, but your food choices still matter—prioritising protein intake helps preserve lean muscle mass during weight loss, whilst adequate fibre intake minimises the constipation that commonly affects GLP-1 users.

Hydration becomes particularly important on weight loss injections, as reduced food intake often means reduced fluid consumption. Aim for 2-3 litres of water daily to support kidney function, prevent constipation, and maintain energy levels. Many patients find that eating smaller, more frequent meals reduces nausea compared to traditional three-meal patterns. Avoiding high-fat meals can also minimise gastrointestinal side effects, as GLP-1 medications slow gastric emptying and fatty foods may sit uncomfortably in the stomach.

Physical activity doesn't need to be intense to enhance results. Even modest increases—walking 30 minutes daily, taking stairs instead of lifts, or incorporating resistance training twice weekly—preserve metabolic rate during weight loss and improve body composition. The appetite suppression from weight loss injections often provides the energy and motivation that previously felt impossible. Our clinical team can provide personalised lifestyle guidance as part of your ongoing care, though we always recommend working with your NHS GP for comprehensive weight management support.

Managing Common Side Effects

Nausea affects approximately 40-50% of patients starting GLP-1 weight loss injections, though it typically improves after 4-6 weeks [1]. Eating smaller portions, avoiding lying down immediately after meals, and choosing bland foods during the adjustment period all help. Ginger tea and anti-nausea wristbands provide relief for some patients. If side effects become intolerable, your prescriber can adjust your dose escalation schedule or consider switching to an alternative medication. Never discontinue treatment abruptly without consulting your prescriber.

Scientific References

1. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. Ludvik, B., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
6. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
7. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment and lifestyle modifications.